My Quote Request
6505-01-362-7422
20 Products
PROSCAR TABLETS
FINASTERIDE TABLETS,USP
NSN, MFG P/N
6505013627422
NSN
6505-01-362-7422
PROSCAR TABLETS
FINASTERIDE TABLETS,USP
NSN, MFG P/N
6505013627422
NSN
6505-01-362-7422
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FINASTERIDE TABLETS 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 5 MG FINASTERIDE; USE FOR BENIGN PROSTATIC HYPERPLASIA
THERAPEUTIC EQUIVALENT: PROSE BY MERCK-SHARP AND DOHME
Related Searches:
92-0933
ANTIDOTE TREATMENT
NSN, MFG P/N
6505013627427
NSN
6505-01-362-7427
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: AUTOINJECTOR, DUAL-CHAMBER: CONTAINING 2 MG OF ATROPINE INJECTION PER 0.7 ML, 2 ML OF PRALIODOXIME CHLORIDE INJECTION, 300 MG PER ML, AND ONE 21 GAGE STERILE NEEDLE; FOR INTRAMUSCULAR USE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIDOTE TREATMENT NERVE AGENT AUTO INJECTOR DUAL-CHAMBER
Related Searches:
ATNAA
ANTIDOTE TREATMENT
NSN, MFG P/N
6505013627427
NSN
6505-01-362-7427
MFG
MERIDIAN MEDICAL TECHNOLOGIES INC.
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: AUTOINJECTOR, DUAL-CHAMBER: CONTAINING 2 MG OF ATROPINE INJECTION PER 0.7 ML, 2 ML OF PRALIODOXIME CHLORIDE INJECTION, 300 MG PER ML, AND ONE 21 GAGE STERILE NEEDLE; FOR INTRAMUSCULAR USE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIDOTE TREATMENT NERVE AGENT AUTO INJECTOR DUAL-CHAMBER
Related Searches:
NDC11704-0777-01
ANTIDOTE TREATMENT
NSN, MFG P/N
6505013627427
NSN
6505-01-362-7427
MFG
MERIDIAN MEDICAL TECHNOLOGIES INC.
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: AUTOINJECTOR, DUAL-CHAMBER: CONTAINING 2 MG OF ATROPINE INJECTION PER 0.7 ML, 2 ML OF PRALIODOXIME CHLORIDE INJECTION, 300 MG PER ML, AND ONE 21 GAGE STERILE NEEDLE; FOR INTRAMUSCULAR USE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIDOTE TREATMENT NERVE AGENT AUTO INJECTOR DUAL-CHAMBER
Related Searches:
DRP 4/8 IND/H MAD
SODA LIME,NF
NSN, MFG P/N
6505013628311
NSN
6505-01-362-8311
MFG
DIVERS SUPPLY INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODASORB
III PROTECTIVE STORAGE FEATURE: CORROSIVE AND POISONOUS
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.500 POUNDS OR 1.130 KILOGRAMS
PRIMARY CONTAINER TYPE: CARTRIDGE
SPECIAL FEATURES: GRANULAR SIZE BETWEEN 4 AND 8 MESH; W/INDICATOR; DISPOSABLE PLASTIC CARTRIDGE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
SODASORB PRE PAK
SODA LIME,NF
NSN, MFG P/N
6505013628311
NSN
6505-01-362-8311
MFG
GRACE W R AND CO DEWEY AND ALMY CHEMICAL DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODASORB
III PROTECTIVE STORAGE FEATURE: CORROSIVE AND POISONOUS
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.500 POUNDS OR 1.130 KILOGRAMS
PRIMARY CONTAINER TYPE: CARTRIDGE
SPECIAL FEATURES: GRANULAR SIZE BETWEEN 4 AND 8 MESH; W/INDICATOR; DISPOSABLE PLASTIC CARTRIDGE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
COLYTE
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION,USP
NSN, MFG P/N
6505013628312
NSN
6505-01-362-8312
COLYTE
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION,USP
NSN, MFG P/N
6505013628312
NSN
6505-01-362-8312
MFG
SCHWARZ PHARMA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.530 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 2.820 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 6.360 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 21.500 GRAMS SODIUM SULFATE, ANHYDROUS ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION 18OZ BT 12S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 510.300 GRAMS OR 18.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 227.10 GRAMS POLYETHYLENE GLYCOL 3350 AND 1.83 GRAMS FLAVOR INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
COLYTE-FLAVORED
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION,USP
NSN, MFG P/N
6505013628312
NSN
6505-01-362-8312
COLYTE-FLAVORED
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION,USP
NSN, MFG P/N
6505013628312
NSN
6505-01-362-8312
MFG
SCHWARZ PHARMA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.530 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 2.820 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 6.360 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 21.500 GRAMS SODIUM SULFATE, ANHYDROUS ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION 18OZ BT 12S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 510.300 GRAMS OR 18.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 227.10 GRAMS POLYETHYLENE GLYCOL 3350 AND 1.83 GRAMS FLAVOR INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00021-4403-13
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION,USP
NSN, MFG P/N
6505013628312
NSN
6505-01-362-8312
NDC00021-4403-13
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION,USP
NSN, MFG P/N
6505013628312
NSN
6505-01-362-8312
MFG
SCHWARZ PHARMA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.530 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 2.820 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 6.360 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 21.500 GRAMS SODIUM SULFATE, ANHYDROUS ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION 18OZ BT 12S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 510.300 GRAMS OR 18.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 227.10 GRAMS POLYETHYLENE GLYCOL 3350 AND 1.83 GRAMS FLAVOR INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00091-4403-13
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION,USP
NSN, MFG P/N
6505013628312
NSN
6505-01-362-8312
NDC00091-4403-13
PEG 3350 AND ELECTROLYTES FOR ORAL SOLUTION,USP
NSN, MFG P/N
6505013628312
NSN
6505-01-362-8312
MFG
SCHWARZ PHARMA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.530 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 2.820 GRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 6.360 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 21.500 GRAMS SODIUM SULFATE, ANHYDROUS ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POLYETHYLENE GLYCOL AND ELECTROLYTES FOR ORAL SOLUTION 18OZ BT 12S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 510.300 GRAMS OR 18.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS 227.10 GRAMS POLYETHYLENE GLYCOL 3350 AND 1.83 GRAMS FLAVOR INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
INFED
IRON DEXTRAN INJECTION,USP
NSN, MFG P/N
6505013628314
NSN
6505-01-362-8314
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS IRON EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IRON DEXTRAN INJECTION USP 2ML AMPUL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00364-3012-47
IRON DEXTRAN INJECTION,USP
NSN, MFG P/N
6505013628314
NSN
6505-01-362-8314
NDC00364-3012-47
IRON DEXTRAN INJECTION,USP
NSN, MFG P/N
6505013628314
NSN
6505-01-362-8314
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS IRON EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IRON DEXTRAN INJECTION USP 2ML AMPUL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC52544-0931-02
IRON DEXTRAN INJECTION,USP
NSN, MFG P/N
6505013628314
NSN
6505-01-362-8314
NDC52544-0931-02
IRON DEXTRAN INJECTION,USP
NSN, MFG P/N
6505013628314
NSN
6505-01-362-8314
MFG
WATSON LABS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS IRON EQUIVALENT PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IRON DEXTRAN INJECTION USP 2ML AMPUL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00074-6660-75
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505013629903
NSN
6505-01-362-9903
NDC00074-6660-75
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505013629903
NSN
6505-01-362-9903
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIEQUIVALENTS SODIUM CHLORIDE INJECTION PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 40ML VIAL 100S
III SUPPLEMENTARY FEATURES: 100 MEQ PER 40 ML
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 25 TO A BOX; SOLD IN MULTIPLES OF 4
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
CARDIZEM CD
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013630019
NSN
6505-01-363-0019
CARDIZEM CD
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013630019
NSN
6505-01-363-0019
MFG
SANOFI-AVENTIS U.S. INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 180.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: PELLET
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 5000.000
CAPSULE TYPE: SOFT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DILTIAZEM EXTENDED-RELEASE CAPSULES USP 180MG 5000S DRUM
PRIMARY CONTAINER TYPE: DRUM
THERAPEUTIC EQUIVALENT: MARION MERRELL DOW
Related Searches:
NDC00088-1796-90
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013630019
NSN
6505-01-363-0019
NDC00088-1796-90
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013630019
NSN
6505-01-363-0019
MFG
SANOFI-AVENTIS U.S. INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 180.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: PELLET
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 5000.000
CAPSULE TYPE: SOFT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DILTIAZEM EXTENDED-RELEASE CAPSULES USP 180MG 5000S DRUM
PRIMARY CONTAINER TYPE: DRUM
THERAPEUTIC EQUIVALENT: MARION MERRELL DOW
Related Searches:
CARDIZEM CD
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013630020
NSN
6505-01-363-0020
CARDIZEM CD
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013630020
NSN
6505-01-363-0020
MFG
SANOFI-AVENTIS U.S. INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 240.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: PELLET
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 5000.000
CAPSULE TYPE: SOFT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DILTIAZEM EXTENDED-RELEASE CAPSULES USP 240MG 5000S DRUM
PRIMARY CONTAINER TYPE: PACKAGE
Related Searches:
NDC00088-1797-90
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013630020
NSN
6505-01-363-0020
NDC00088-1797-90
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013630020
NSN
6505-01-363-0020
MFG
SANOFI-AVENTIS U.S. INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 240.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: PELLET
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 5000.000
CAPSULE TYPE: SOFT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DILTIAZEM EXTENDED-RELEASE CAPSULES USP 240MG 5000S DRUM
PRIMARY CONTAINER TYPE: PACKAGE
Related Searches:
CEPACOL
CETYLPYRIDINIUM CHLORIDE LOZENGES,USP
NSN, MFG P/N
6505013630558
NSN
6505-01-363-0558
CEPACOL
CETYLPYRIDINIUM CHLORIDE LOZENGES,USP
NSN, MFG P/N
6505013630558
NSN
6505-01-363-0558
MFG
COMBE INCORPORATED
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CETYLPYRIDINIUM CHLORIDE LOZENGES USP 432S PG
PRIMARY CONTAINER CONTENT QUANTITY: 9.000 LOZENGES
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 2 STRIP
PRIMARY CONTAINER TYPE: STRIP
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 18 LOZENGES PER BOX; 24 BOXES PER PG
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
CEPACOL LOZENGES
CETYLPYRIDINIUM CHLORIDE LOZENGES,USP
NSN, MFG P/N
6505013630558
NSN
6505-01-363-0558
CEPACOL LOZENGES
CETYLPYRIDINIUM CHLORIDE LOZENGES,USP
NSN, MFG P/N
6505013630558
NSN
6505-01-363-0558
MFG
COMBE INCORPORATED
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CETYLPYRIDINIUM CHLORIDE LOZENGES USP 432S PG
PRIMARY CONTAINER CONTENT QUANTITY: 9.000 LOZENGES
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 2 STRIP
PRIMARY CONTAINER TYPE: STRIP
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 18 LOZENGES PER BOX; 24 BOXES PER PG
TOTAL PRIMARY CONTAINER QUANTITY: 24